TransMedics (TMDX) Change in Accured Expenses (2018 - 2026)
TransMedics (TMDX) recorded quarterly Change in Accured Expenses of -$3.1 million in Q1 2026, down 144.57% quarter-over-quarter from $7.0 million in Q4 2025, and up 33.14% on a YoY basis from -$2.3 million in Q1 2025.
TransMedics (TMDX) Change in Accured Expenses (2018 - 2026) Analysis & Trends
TransMedics' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$3.1 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 33.14% year-over-year to -$3.1 million; the TTM figure through Mar 2026 stood at $19.2 million (up 475.32% YoY), while the FY2025 annual figure was $17.7 million, up 122.9% from the prior year.
- Change in Accured Expenses was -$3.1 million for Q1 2026 at TransMedics, down from $7.0 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $13.1 million in Q3 2025 to a low of -$4.6 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged $2.4 million across 5 years, with a median of $2.2 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses soared 86450.0% in 2023, then slumped 9377.55% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $3.4 million in 2022, then surged by 44.93% to $5.0 million in 2023, then slumped by 53.45% to $2.3 million in 2024, then surged by 199.74% to $7.0 million in 2025, then slumped by 144.57% to -$3.1 million in 2026.
- The last three Change in Accured Expenses figures came in at -$3.1 million (Q1 2026), $7.0 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | TransMedics | 2.72 Bn | 2.26 Bn | 101.16 Mn | -3.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.11 Mn |
| Mar 31, 2026 | -3.11 Mn |
| Dec 31, 2025 | 6.97 Mn |
| Dec 31, 2025 | 6.97 Mn |
| Sep 30, 2025 | 13.14 Mn |
| Sep 30, 2025 | 13.14 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | -4.64 Mn |
| Mar 31, 2025 | -4.64 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Jun 30, 2024 | 679,000.00 |
| Jun 30, 2024 | 679,000.00 |
| Mar 31, 2024 | -49,000.00 |
| Mar 31, 2024 | -49,000.00 |
| Dec 31, 2023 | 4.99 Mn |
| Dec 31, 2023 | 4.99 Mn |